Victor Perlroth, Kodiak Sciences CEO
February 23, 2022 07:27 AM EST
R&D

Ko­di­ak’s Eylea con­tender falls flat in PhI­II, wip­ing out near­ly $2B in val­ue

Jason Mast

Editor

Last Ju­ly, Ko­di­ak Sci­ences turned down a $125 mil­lion pay­ment from the in­vest­ment firm Bak­er Bros. The sec­ond and fi­nal in­stall­ment from a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times